Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.
